Search - tctmd.com

Displaying 1 - 20 of 227

Sort: Relevancy | Date

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Conference News AHA 2016

AHA/ACC Issue Updated PAD Guidelines

L.A. McKeown

November 14, 2016

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

Presentation TCT 2016

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Presenter: Fernando Alfonso, Juan F. Granada

November 01, 2016

Presentation TCT 2016

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

Presenter: Fernando Alfonso, Juan F. Granada, Azeem Latib

November 01, 2016

Presentation TCT 2016

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

Presenter: Fernando Alfonso, Juan F. Granada, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

November 01, 2016

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Koen Deloose, William A. Gray, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Presenter: Koen Deloose, William A. Gray, Lawrence A. Garcia

November 01, 2016

Presentation TCT 2016

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

Presenter: Koen Deloose, William A. Gray

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Overview of the Clinical Trials for Drug-Coated Balloons

Presenter: Schuyler Jones, Misti Malone, George Papandreou

October 30, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Daily News

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Caitlin E. Cox

August 17, 2016

Advertisement

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

AHA/ACC Issue Updated PAD Guidelines

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Novel DCB Coatings and Alternative Drugs: Are We Reaching the End of the Road?

Methods and Technologies to Improve DCB Outcomes: Does the Data Support Their Use?

DCB for De Novo Lesions: Clinical Applications and Technical Pitfalls

DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!

Designing a Complication-Free DCB: Is It Possible or Necessary?

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention?

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Overview of the Clinical Trials for Drug-Coated Balloons

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

TCTMD’s Top 10 Most Popular Stories for August 2016

Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content